Catalyst Funds Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-68	Closed	-$3.21K	–	902
2024 Q3	$3.21K	Hold	68	–	–	﹤0.01%	1257
2024 Q2	$3.42K	Buy	+68	New	+$3.42K	﹤0.01%	1095